In a 176‑kg patient with type 2 diabetes on insulin glargine (Lantus) 30 U daily and insulin aspart (Novolog) 15 U per meal, impaired renal function (creatinine 1.28 mg/dL, eGFR ≈ 68 mL/min), admitted for COPD exacerbation and starting prednisone 60 mg daily, what NPH insulin dose and insulin‑to‑carbohydrate ratio should be used?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

NPH Insulin Dosing for Glucocorticoid-Induced Hyperglycemia

For this 176-kg patient starting prednisone 60 mg daily, add NPH insulin 36 units each morning (given with the prednisone dose) to the existing basal-bolus regimen, and increase prandial insulin aspart to 20-25 units with lunch and dinner while keeping breakfast at 15 units.

Rationale and Calculation

The most recent and specific guideline for glucocorticoid-induced hyperglycemia 1 provides clear weight-based dosing: NPH should be dosed at 0.1-0.4 units/kg based on prednisone dose increments, where each 10 mg of prednisone corresponds to 0.1 units/kg of NPH.

For prednisone 60 mg:

  • 60 mg ÷ 10 = 6 increments
  • 6 × 0.1 units/kg = 0.6 units/kg
  • However, the guideline caps this at 0.4 units/kg maximum
  • 176 kg × 0.2 units/kg = 35.2 units (using mid-range dosing given moderate renal impairment)
  • Round to 36 units NPH given each morning with prednisone

Why NPH Over Continuing Lantus Alone

NPH's pharmacokinetic profile matches prednisone-induced hyperglycemia better than long-acting basal insulin 1, 2, 1. Prednisone peaks 4-6 hours after morning dosing and causes disproportionate daytime hyperglycemia while glucose often normalizes overnight 2. NPH peaks 4-8 hours after injection, providing coverage during the period of maximal steroid-induced insulin resistance.

The 2025 ADA Standards explicitly state: "Consider dosing NPH in the morning for steroid-induced hyperglycemia" 3.

Prandial Insulin Adjustment (Insulin-to-Carbohydrate Ratio)

Current Situation Analysis

  • Current prandial: 15 units × 3 meals = 45 units/day
  • Current basal: 30 units Lantus
  • Total daily dose (TDD) = 75 units

Recommended Approach

Increase prandial insulin proportionally for later meals where steroid effect is maximal 1:

  • Breakfast: 15 units (maintain current dose)
  • Lunch: 20-25 units (increase by 33-67%)
  • Dinner: 20-25 units (increase by 33-67%)

This distributes additional insulin coverage when prednisone-induced hyperglycemia peaks (afternoon/evening) rather than using a fixed ICR.

If Using Carbohydrate Counting

The current regimen suggests approximately 1 unit per 10-12 grams of carbohydrate (assuming 150-180g carb intake daily). With steroids:

  • Morning: 1:10-12 ratio (unchanged)
  • Lunch/Dinner: 1:8-10 ratio (more aggressive)

Critical Considerations for Renal Impairment

Insulin Clearance with eGFR 68 mL/min

Both insulin glargine and aspart pharmacokinetics are minimally affected by moderate renal impairment (eGFR 60-89 mL/min) 4, 5, 6. However, insulin clearance decreases as renal function declines, increasing hypoglycemia risk 7.

Key adjustments:

  • Start NPH at the lower-middle range (0.2 units/kg rather than 0.3-0.4 units/kg) 1
  • Monitor glucose more frequently (every 4-6 hours initially)
  • Reduce doses by 10-20% if unexplained hypoglycemia occurs 3, 8, 3

Obesity Factor (176 kg)

Increasing obesity decreases apparent insulin clearance per kg but increases total insulin requirements 4. The weight-based dosing already accounts for this. No additional adjustment needed beyond the calculated dose.

Monitoring and Titration Protocol

Initial Phase (Days 1-3)

  • Check fasting, pre-meal, and bedtime glucose
  • Target fasting glucose 100-140 mg/dL, pre-meal <180 mg/dL 9
  • If fasting glucose remains elevated despite NPH, this suggests inadequate basal coverage—consider increasing NPH by 10% daily 1

Adjustment Algorithm 1

If daytime glucose >180 mg/dL:

  • Increase NPH by 4-6 units (10%) every 1-2 days

If nocturnal hypoglycemia (<70 mg/dL):

  • Decrease NPH by 10-20% 3
  • Consider that prednisone effect wanes overnight—NPH may cause nocturnal lows

If post-meal glucose >180 mg/dL:

  • Increase corresponding meal's prandial insulin by 2-3 units

Common Pitfalls to Avoid

  1. Do NOT continue Lantus at full dose when adding NPH—this creates overlapping basal coverage and increases hypoglycemia risk. The guideline approach is to add NPH to existing basal insulin 1, but given the high steroid dose, consider reducing Lantus to 20-25 units if hypoglycemia occurs.

  2. Do NOT use the same prandial doses for all meals—steroids cause disproportionate afternoon/evening hyperglycemia 2, 1. Weight doses toward lunch and dinner.

  3. Do NOT delay NPH initiation—start on day 1 of prednisone in patients with pre-existing diabetes 1. Waiting leads to poor glycemic control.

  4. Do NOT use sliding scale insulin (SSI) alone—this is reactive rather than proactive and leads to inadequate control 9. Always use scheduled insulin.

  5. Watch for rapid glucose changes when prednisone is tapered—insulin requirements will drop proportionally. Reduce NPH by 10-20% for each 10-20 mg reduction in prednisone 1.

Alternative Approach if NPH Unavailable

If NPH is not available, the alternative is basal-bolus intensification 1:

  • Continue Lantus 30 units
  • Calculate new TDD at 0.5-0.6 units/kg = 88-106 units
  • Distribute as 40% basal (35-42 units Lantus) and 60% prandial (53-64 units total)
  • Divide prandial with larger proportions at lunch and dinner

However, this approach has higher hypoglycemia risk and less physiologic coverage compared to NPH 1.

Related Questions

For a 61‑year‑old man with pancreatogenic diabetes, weighing 53 kg and normal renal function, who is receiving only clear liquids after an insulin drip, should his basal insulin glargine (Lantus) dose be 10 units or 12 units?
For a 60‑year‑old female weighing 53 kg with chronic kidney disease (creatinine 2.07 mg/dL, eGFR ≈ 27 mL/min) on prednisone 5 mg daily and currently using insulin glargine (Lantus) 18 U at 8 am with rapid‑acting insulin (ICR 11 U per 50 g carbohydrate), what should her insulin‑to‑carbohydrate ratio (ICR), insulin sensitivity factor (ISF), and basal insulin (Lantus) dose be?
For a 46‑year‑old man with type 3c diabetes, weight 88 kg, impaired renal function (creatinine 1.18 mg/dL, eGFR ≈ 77 mL/min) who is on Lantus (insulin glargine) 10 U daily, insulin‑to‑carbohydrate ratio 10 g per unit, and insulin‑sensitivity factor 50 mg/dL per unit, is it appropriate to increase basal Lantus to 15 U, adjust the insulin‑sensitivity factor to 25 mg/dL per unit, and set the insulin‑to‑carbohydrate ratio to 1 U per 8 g carbohydrate?
What should the basal insulin glargine (Lantus) dose, insulin‑sensitivity factor, and insulin‑to‑carbohydrate ratio be for a 35‑year‑old male, 80 kg, with serum creatinine 1.18 mg/dL (eGFR 87 mL/min/1.73 m²), fasting blood glucose 73 mg/dL while on 32 U nightly Lantus, and current ISF 25 mg/dL per unit and ICR 10 g per unit?
For a 46‑year‑old man with type 3c diabetes, weight 88 kg, creatinine 1.18 mg/dL (eGFR ≈ 77 mL/min) on Lantus (insulin glargine) 10 U daily, insulin‑to‑carbohydrate ratio 10 g per unit, insulin sensitivity factor 50 mg/dL per unit, with capillary glucose 263 mg/dL at 1700 h, 231 mg/dL at 0200 h, and 284 mg/dL at 0700 h after meals of 80 g, 82 g, and 34 g carbohydrates, what should the basal insulin dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?
What is the recommended next-line treatment for tinea corporis resistant to itraconazole and griseofulvin?
Is methenamine appropriate for urinary‑tract infection prophylaxis in a patient with a history of bladder cancer, provided the urine can be kept acidic and there is no active infection?
What are the common precipitants and triggers of hepatic encephalopathy?
Which fetal heart rate patterns observed during continuous monitoring in a 34‑week gestation patient undergoing laparoscopic cholecystectomy under general anesthesia indicate the need for immediate delivery?
Is red yeast rice more extensively studied than berberine for lowering LDL-cholesterol?
What lifestyle modifications can help prevent and treat tinea cruris (groin fungal infection)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.